Christopher Navara to Tubulin
This is a "connection" page, showing publications Christopher Navara has written about Tubulin.
Connection Strength
0.223
-
Uckun FM, Mao C, Jan ST, Huang H, Vassilev AO, Navara CS, Narla RK. Spongistatins as tubulin targeting agents. Curr Pharm Des. 2001 Sep; 7(13):1291-6.
Score: 0.048
-
Uckun FM, Sudbeck EA, Mao C, Ghosh S, Liu XP, Vassilev AO, Navara CS, Narla RK. Structure-based design of novel anticancer agents. Curr Cancer Drug Targets. 2001 May; 1(1):59-71.
Score: 0.047
-
Jan ST, Mao C, Vassilev AO, Navara CS, Uckun FM. COBRA-1, a rationally-designed epoxy-THF containing compound with potent tubulin depolymerizing activity as a novel anticancer agent. Bioorg Med Chem Lett. 2000 Jun 05; 10(11):1193-7.
Score: 0.044
-
Uckun FM, Mao C, Vassilev AO, Navara CS, Narla RK, Jan ST. A rationally designed anticancer drug targeting a unique binding cavity of tubulin. Bioorg Med Chem Lett. 2000 May 15; 10(10):1015-8.
Score: 0.044
-
Simerly C, Zoran SS, Payne C, Dominko T, Sutovsky P, Navara CS, Salisbury JL, Schatten G. Biparental inheritance of gamma-tubulin during human fertilization: molecular reconstitution of functional zygotic centrosomes in inseminated human oocytes and in cell-free extracts nucleated by human sperm. Mol Biol Cell. 1999 Sep; 10(9):2955-69.
Score: 0.042